Operating Expenses Summary of NGL Fine-Chem Limited

NGL Fine-Chem Limited's latest annual operating expenses in 2023 was 1.75 Billion INR , down -28.86% from previous year.
NGL Fine-Chem Limited's latest quarterly operating expenses in 2024 Q1 was 223.14 Million INR , down -51.44% from previous quarter.
NGL Fine-Chem Limited reported a annual operating expenses of 1.14 Billion INR in annual operating expenses 2022, up 6.22% from previous year.
NGL Fine-Chem Limited reported a annual operating expenses of 1.08 Billion INR in annual operating expenses 2021, up 41.5% from previous year.
NGL Fine-Chem Limited reported a quarterly operating expenses of 328.95 Million INR for 2023 Q2, up 9.25% from previous quarter.
NGL Fine-Chem Limited reported a quarterly operating expenses of 816.16 Million INR for 2023 FY, down -28.86% from previous quarter.

Annual Operating Expenses Chart of NGL Fine-Chem Limited (2023 - 2007)

Historical Annual Operating Expenses of NGL Fine-Chem Limited (2023 - 2007)

Year	Operating Expenses	Operating Expenses Growth
2023	1.75 Billion INR	-28.86%
2022	1.14 Billion INR	6.22%
2021	1.08 Billion INR	41.5%
2020	763.31 Million INR	7.97%
2019	706.97 Million INR	20.56%
2018	586.38 Million INR	21.98%
2017	480.72 Million INR	21.57%
2016	395.44 Million INR	7.94%
2015	366.34 Million INR	6.72%
2014	343.26 Million INR	14.88%
2013	298.8 Million INR	39.72%
2012	213.86 Million INR	42.15%
2011	150.45 Million INR	2452.45%
2010	5.89 Million INR	12.52%
2009	5.23 Million INR	-94.49%
2008	95.15 Million INR	46.59%
2007	64.91 Million INR	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	223.14 Million INR	-51.44%
2023 Q2	328.95 Million INR	9.25%
2023 FY	816.16 Million INR	-28.86%
2023 Q4	245.38 Million INR	15.14%
2023 Q3	213.12 Million INR	-35.21%
2023 Q1	301.1 Million INR	-0.38%
2022 FY	1.14 Billion INR	6.22%
2022 Q1	314.67 Million INR	9.86%
2022 Q2	281.45 Million INR	-10.56%
2022 Q3	265.6 Million INR	-5.63%
2022 Q4	302.26 Million INR	13.8%
2021 Q1	222.18 Million INR	17.58%
2021 Q4	286.43 Million INR	-1.63%
2021 FY	1.08 Billion INR	41.5%
2021 Q3	291.17 Million INR	2.98%
2021 Q2	282.73 Million INR	27.26%
2020 Q1	141.16 Million INR	-12.15%
2020 Q2	200.9 Million INR	42.32%
2020 FY	763.31 Million INR	7.97%
2020 Q4	188.95 Million INR	-18.61%
2020 Q3	232.17 Million INR	15.57%
2019 Q2	183.08 Million INR	2.79%
2019 FY	706.97 Million INR	20.56%
2019 Q3	183.72 Million INR	0.35%
2019 Q1	178.1 Million INR	59.25%
2019 Q4	160.68 Million INR	-12.54%
2018 Q2	165.66 Million INR	-0.01%
2018 Q1	165.68 Million INR	20.09%
2018 Q3	154.4 Million INR	-6.8%
2018 Q4	111.84 Million INR	-27.56%
2018 FY	586.38 Million INR	21.98%
2017 Q3	133.72 Million INR	17.64%
2017 Q1	113.73 Million INR	3.56%
2017 FY	480.72 Million INR	21.57%
2017 Q4	137.95 Million INR	3.17%
2017 Q2	113.67 Million INR	-0.05%
2016 Q1	93.3 Million INR	-0.91%
2016 Q2	91.25 Million INR	-2.21%
2016 FY	395.44 Million INR	7.94%
2016 Q4	109.82 Million INR	11.82%
2016 Q3	98.21 Million INR	7.63%
2015 FY	366.34 Million INR	6.72%
2015 Q4	94.16 Million INR	7.87%
2015 Q3	87.29 Million INR	-3.84%
2015 Q2	90.78 Million INR	1.13%
2015 Q1	89.76 Million INR	-3.05%
2014 Q4	92.59 Million INR	4.49%
2014 Q3	88.61 Million INR	6.7%
2014 Q2	83.05 Million INR	2.73%
2014 Q1	80.84 Million INR	8.22%
2014 FY	343.26 Million INR	14.88%
2013 Q1	74.92 Million INR	22.3%
2013 Q3	78.45 Million INR	6.39%
2013 Q4	74.7 Million INR	-4.78%
2013 FY	298.8 Million INR	39.72%
2013 Q2	73.74 Million INR	-1.57%
2012 Q1	43.76 Million INR	15.76%
2012 Q3	58.4 Million INR	15.57%
2012 Q2	50.53 Million INR	15.47%
2012 FY	213.86 Million INR	42.15%
2012 Q4	61.26 Million INR	4.9%
2011 FY	150.45 Million INR	2452.45%
2011 Q4	37.8 Million INR	-8.12%
2011 Q3	41.15 Million INR	0.0%
2010 FY	5.89 Million INR	12.52%
2009 FY	5.23 Million INR	-94.49%
2008 FY	95.15 Million INR	46.59%
2008 Q4	27.9 Million INR	0.0%
2007 FY	64.91 Million INR	0.0%
2007 Q4	14.08 Million INR	0.0%

Peer Operating Expenses Comparison of NGL Fine-Chem Limited

Name	Operating Expenses	Operating Expenses Difference
Abbott India Limited	5.98 Billion INR	70.762%
Cipla Limited	59.21 Billion INR	97.044%
Gland Pharma Limited	14.65 Billion INR	88.058%
GlaxoSmithKline Pharmaceuticals Limited	4.35 Billion INR	59.832%
Kopran Limited	1.41 Billion INR	-23.623%
Marksans Pharma Limited	3.28 Billion INR	46.792%
Pfizer Limited	4.33 Billion INR	59.646%
Sanofi India Limited	4.13 Billion INR	57.642%
SMS Pharmaceuticals Limited	769.2 Million INR	-127.54%
TTK Healthcare Limited	3.72 Billion INR	52.967%

Global Stocks Search

NGL Fine-Chem Limited (NGLFINE.NS)

Operating Expenses Summary of NGL Fine-Chem Limited

Annual Operating Expenses Chart of NGL Fine-Chem Limited (2023 - 2007)

Historical Annual Operating Expenses of NGL Fine-Chem Limited (2023 - 2007)

Peer Operating Expenses Comparison of NGL Fine-Chem Limited